Karen Knudsen, Chief Executive Officer at Parker Institute for Cancer Immunotherapy, shared a post on LinkedIn:
“Terrific presentation from Kedar Kirtane at American Society of Clinical Oncology (ASCO). Quality, reminding us that the complexity of patient access to clinical trials remains multi factorial. As discussed, both the private and public sector must work in concert to get potentially curative therapeutics to patients.
Put simply, cancer research saves lives, and federal funding for research is essential.”
More posts featuring Karen Knudsen.